Skip to content

Evaluation of Usefulness of Contrast Enhanced MRI in Evaluation of Spine Trauma: Prospective Study

Evaluation of Usefulness of Contrast Enhanced MRI in Evaluation of Spine Trauma: Prospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01880944
Enrollment
300
Registered
2013-06-19
Start date
2013-06-24
Completion date
2017-02-14
Last updated
2018-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma

Keywords

spine, trauma, MRI, contrast

Brief summary

Non-contrast MRI with T2 fat suppression has been a useful imaging modality in evaluation spinal trauma. However, the role of contrast enhancement has not investigated in patients with spinal trauma. Therefore, this prospective study aims to evaluate the usefulness of contrast enhanced MRI for spinal trauma W/U clinically. The study hypothesis is that there is no additional gain in addition of contrast enhanced study to routine non-contrast MRI.

Interventions

OTHERNC-MRI, CE-MRI

non-contrast spine MRI(NC-MRI) contrast-enhanced spine MRI(CE-MRI)

Sponsors

Bayer
CollaboratorINDUSTRY
Seoul National University Bundang Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients who provided the informed consent 2. Patients with spinal trauma 3. Patients with age of 19 years or more

Exclusion criteria

1. Relative contraindication of MR contrast * previous history of any adverse event after injection of magnetic resonance contrast * pregnant or breast-feeding state * within 2 weeks after liver transplantation * epileptic disorder 2. Patients impossible with follow-up period of at least 2 months clinically 3. Patients with severely impaired renal function of estimated glomerular filtration rate (GFR) \< 30 mL/min/1.73m2 and/or on dialysis 4. patients with age less than 19 years

Design outcomes

Primary

MeasureTime frameDescription
The rate (%) of change of treatment option between non-surgery vs. surgery, after review of enhanced MRI finding, compared with non-enhanced MRI only2 monthsThe rate (%) of change of treatment option between non-surgery vs. surgery, after review of enhanced MRI finding, compared with non-enhanced MRI only
Confidence level2 monthsConfidence level (1, definitely negative; 2, probably negative; 3, equivocal; 4, probably positive; 5, definitely positive) for lesion of spinal body, posterior compartment, soft tissue (posterior ligamentous complex of thoracolumbar spine and discoligamentous complex of cervical spine), spinal cord, and epidural/subdural hematoma/hemorrhage

Secondary

MeasureTime frameDescription
Diagnostic accuracy of non-enhanced and enhanced MRI2 monthsDiagnostic accuracy of non-enhanced and enhanced MRI in patients with operations for each anatomical lesion (e.g. fracture of body, fracture of posterior compartment, soft tissue injury, cord injury, and epidural/subdural hematoma)
Inter- and intra-reader agreement of confidence level2 monthsInter- and intra-reader agreement of confidence level between non-enhanced and enhanced MRI

Other

MeasureTime frameDescription
Prognostic value of enhanced MRI2 monthsPrognostic value of enhanced MRI, compared with non-enhanced MRI, based on clinical feature during follow-up period: TLICS(thoracolumbar injury classification and severity score) or SLIC(subaxial cervical injury classification system)score for non-surgery group vs. surgery group
The rate (%) of change of treatment plan2 monthsThe rate (%) of change of treatment plan between posterior vs. anterior vs. anterior & posterior approaches, after review of enhanced MRI finding, compared with non-enhanced MRI only

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026